These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31775361)

  • 1. The Precursor for Nerve Growth Factor (proNGF) in Thyroid Cancer Lymph Node Metastases: Correlation with Primary Tumour and Pathological Variables.
    Rowe CW; Dill T; Faulkner S; Gedye C; Paul JW; Tolosa JM; Jones M; King S; Smith R; Hondermarck H
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31775361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of CEP78 and WDR62 gene expressions in differentiated thyroid carcinoma: Possible predictors of lateral lymph node metastasis.
    Hammad MO; Elabbasy LM; Abd Elghaffar MA; Zaki MMA; Bazeed FB; Zahran MA
    Asia Pac J Clin Oncol; 2019 Oct; 15(5):e154-e161. PubMed ID: 30884127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of VHL tumor suppressor mRNA and miR-92a in papillary thyroid carcinoma and their correlation with clinical and pathological parameters.
    Todorović L; Stanojević B; Mandušić V; Petrović N; Živaljević V; Paunović I; Diklić A; Saenko V; Yamashita S
    Med Oncol; 2018 Jan; 35(2):17. PubMed ID: 29340905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-regulatory potential of vascular endothelial growth factor-A and vascular endothelial growth factor-C in thyroid carcinoma.
    Salajegheh A; Pakneshan S; Rahman A; Dolan-Evans E; Zhang S; Kwong E; Gopalan V; Lo CY; Smith RA; Lam AK
    Hum Pathol; 2013 Oct; 44(10):2204-12. PubMed ID: 23845470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ProNGF is a potential diagnostic biomarker for thyroid cancer.
    Faulkner S; Roselli S; Demont Y; Pundavela J; Choquet G; Leissner P; Oldmeadow C; Attia J; Walker MM; Hondermarck H
    Oncotarget; 2016 May; 7(19):28488-97. PubMed ID: 27074571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of thyroglobulin measurement with fine-needle aspiration biopsy for lymph node metastases in patients with a history of differentiated thyroid cancer.
    Zhang HS; Wang RJ; Fu QF; Gao S; Sun BT; Sun H; Ma QJ
    Asian Pac J Cancer Prev; 2014; 15(24):10905-9. PubMed ID: 25605199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated expression of nuclear protein kinase CK2α as a poor prognosis indicator in lymph node cancerous metastases of human thyroid cancers.
    Guo M; Liu C; Qi FJ; Zhang XM; Ren LL; Liu YM; Meng ZC; Zhu ZT; Xiao JY
    Asian Pac J Cancer Prev; 2014; 15(17):7425-32. PubMed ID: 25227853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma.
    Min JJ; Chung JK; Lee YJ; Jeong JM; Lee DS; Jang JJ; Lee MC; Cho BY
    Eur J Nucl Med; 2001 May; 28(5):639-45. PubMed ID: 11383871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic variables of papillary and follicular thyroid carcinoma patients with lymph node metastases and without distant metastases.
    Lin JD; Liou MJ; Chao TC; Weng HF; Ho YS
    Endocr Relat Cancer; 1999 Mar; 6(1):109-15. PubMed ID: 10732793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of p53 protein expression in papillary thyroid carcinoma.
    Morita N; Ikeda Y; Takami H
    World J Surg; 2008 Dec; 32(12):2617-22. PubMed ID: 18836853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncoproteins and tumor progression in papillary thyroid carcinoma: presence of epidermal growth factor receptor, c-erbB-2 protein, estrogen receptor related protein, p21-ras protein, and proliferation indicators in relation to tumor recurrences and patient survival.
    Akslen LA; Varhaug JE
    Cancer; 1995 Nov; 76(9):1643-54. PubMed ID: 8635070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The precursor for nerve growth factor (proNGF) is not a serum or biopsy-rinse biomarker for thyroid cancer diagnosis.
    Rowe CW; Faulkner S; Paul JW; Tolosa JM; Gedye C; Bendinelli C; Wynne K; McGrath S; Attia J; Smith R; Hondermarck H
    BMC Endocr Disord; 2019 Nov; 19(1):128. PubMed ID: 31775768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of valosin-containing protein (p97) is correlated with disease recurrence in follicular thyroid cancer.
    Yamamoto S; Tomita Y; Uruno T; Hoshida Y; Qiu Y; Iizuka N; Nakamichi I; Miyauchi A; Aozasa K
    Ann Surg Oncol; 2005 Nov; 12(11):925-34. PubMed ID: 16189643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strong expression of HBME-1 associates with high-risk clinicopathological factors of papillary thyroid carcinoma.
    Dencic TM; Savin SB; Selemetjev SA; Paskas SD; Zivaljevic VR; Bozic VD; Cvejic DS
    Pathol Oncol Res; 2015 Jul; 21(3):735-42. PubMed ID: 25577274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Wnt/β-catenin pathway drives increased cyclin D1 levels in lymph node metastasis in papillary thyroid cancer.
    Zhang J; Gill AJ; Issacs JD; Atmore B; Johns A; Delbridge LW; Lai R; McMullen TP
    Hum Pathol; 2012 Jul; 43(7):1044-50. PubMed ID: 22204713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The significance of lymph node status in papillary and follicular thyroid gland carcinoma for the nuclear medicine physician].
    Farahati J; Mörtl M; Reiners C
    Zentralbl Chir; 2000; 125(10):830-4. PubMed ID: 11098578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of sialic fibronectin correlates with lymph node metastasis of thyroid malignant neoplasmas.
    Takeyama H; Kyoda S; Okamoto T; Manome Y; Watanabe M; Kinoshita S; Uchida K; Sakamoto A; Morikawa T
    Anticancer Res; 2011 Apr; 31(4):1395-8. PubMed ID: 21508391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases.
    Yu XM; Lo CY; Chan WF; Lam KY; Leung P; Luk JM
    Clin Cancer Res; 2005 Nov; 11(22):8063-9. PubMed ID: 16299237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum vascular endothelial growth factor levels are elevated in metastatic differentiated thyroid cancer but not increased by short-term TSH stimulation.
    Tuttle RM; Fleisher M; Francis GL; Robbins RJ
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1737-42. PubMed ID: 11932308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SSTR2A expression in medullary thyroid carcinoma is correlated with longer survival.
    de Vries LH; Lodewijk L; Willems SM; Dreijerink KMA; de Keizer B; van Diest PJ; Schepers A; Bonenkamp HJ; van Engen-van Grunsven IACH; Kruijff S; van Hemel BM; Links TP; Nieveen van Dijkum EJM; van Eeden S; Valk GD; Borel Rinkes IHM; Vriens MR
    Endocrine; 2018 Dec; 62(3):639-647. PubMed ID: 30128959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.